INVESTOR RELATIONS
Corporate Profile
At GlycoMimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. Our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments.
GlycoMimetics is a clinical-stage biotechnology company. We use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. Since the company’s inception in 2003, we have developed a robust, diversified product pipeline.
Volume
11:08 am EST on Jan 31,2023
Copyright Refinitiv. Minimum 15 minutes delayed.
News
December 12, 2022
November 9, 2022
November 8, 2022
Events
Nov 17, 2022 10:50 AM EST
Nov 9, 2022 8:30 AM EST
Sep 14, 2022 3:00 PM EDT